Telbivudine monotherapy for HIV-HBV coinfected patients: an open explorative study.

Telbivudine monotherapy for HIV-HBV coinfected patients: an open explorative study. - THH

Status

Unknown

Phases

Phase 4

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32543

Enrollment

Registered

2008-08-27

Start date

2008-09-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatitis B

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: HIV infected no HAART and HBV infected needing treatment

Exclusion criteria

Exclusion criteria: HAART indicated

Design outcomes

Primary

Measure	Time frame
Resistance development	—

Secondary

Measure	Time frame
-	—

Countries

Netherlands

Outcome results